| Issue 1061: June 18, 2013 TOP STORIES
IAC HANDOUTS
FEATURED RESOURCES JOURNAL ARTICLES AND NEWSLETTERS
TOP STORIES Reminder: May issues of Needle Tips and Vaccinate Adults available online The May 2013 issues of Needle Tips and Vaccinate Adults are available online. Vaccinate Adults is an abbreviated version of Needle Tips with the pediatric content removed. Click on the images below to download the entire May 2013 issues (PDF) of Needle Tips and/or Vaccinate Adults.   Needle Tips: View the table of contents, magazine viewer, and back issues. Vaccinate Adults: View the table of contents, magazine viewer, and back issues. Back to top CDC publishes recommendations for preventing measles, rubella, congenital rubella syndrome, and mumps On June 14, CDC published Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013: Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP). A portion of the summary section is reprinted below. This report is a compendium of all current recommendations for the prevention of measles, rubella, congenital rubella syndrome (CRS), and mumps. The report presents the recent revisions adopted by the Advisory Committee on Immunization Practices (ACIP) on October 24, 2012, and also summarizes all existing ACIP recommendations that have been published previously during 1998–2011 . . . . Currently, ACIP recommends 2 doses of MMR vaccine routinely for children with the first dose administered at age 12 through 15 months and the second dose administered at age 4 through 6 years before school entry. Two doses are recommended for adults at high risk for exposure and transmission (e.g., students attending colleges or other post-high school educational institutions, healthcare personnel, and international travelers) and 1 dose for other adults aged ≥18 years. For prevention of rubella, 1 dose of MMR vaccine is recommended for persons aged ≥12 months. At the October 24, 2012 meeting, ACIP adopted the following revisions, which are published here for the first time. These included:
Related Links Back to top CDC publishes report summarizing U.S. influenza activity during the 2013–14 influenza season CDC published Influenza Activity—United States, 2012–13 Season and Composition of the 2013–14 Influenza Vaccine in the June 14 issue of MMWR (pages 473–479). A press summary of the article is reprinted below. During 2012–13, influenza A(H3) viruses predominated in the United States overall during the influenza season, followed by influenza B viruses, while pH1N1 viruses were identified rarely. Compared with recent influenza seasons, this season began earlier, and also had a higher percentage of outpatient visits for influenza-like illness, higher rates of hospitalizations, and more deaths attributed to pneumonia and influenza. The age group with the highest hospitalization rate were among people 65 years and older, accounting for more than half of all reported influenza-associated hospitalizations. The 2012–13 influenza season began early, and was relatively more severe than recent influenza seasons, particularly for people 65 years and older. This season is an example of the serious public health toll that influenza can take, and underscores the importance of influenza vaccination and treatment. Back to top FDA approves Fluzone (sanofi pasteur) as the third quadrivalent influenza vaccine licensed for U.S. use On June 7, FDA approved a request by sanofi pasteur to supplement its biologics license application for Fluzone influenza virus vaccine to include a quadrivalent formulation for use in people age 6 months and older. Fluzone quadrivalent is the third quadrivalent influenza vaccine to receive FDA approval. FDA approved MedImmune's FluMist quadrivalent on February 29, 2012, and GlaxoSmithKline's Fluarix quadrivalent on December 14, 2012. Related Links Back to top IAC Spotlight! Timeline of historic events related to vaccines and immunization Looking for a timeline of events specific to the history of immunization? Look no further. IAC recently updated its Historic Dates and Events Related to Vaccines and Immunization web page. A brief description of the event and its date are displayed in a two-column chart. IAC offers it as a handy quick link at www.immunize.org/timeline The listing of historic events is by no means exhaustive. If you know of an event that you would like included on the timeline, please email admin@immunize.org with the details. Back to top IAC HANDOUTS IAC updates its standing orders templates for administering meningococcal vaccine IAC recently updated its two standing orders templates for administering meningococcal vaccine. The two standing orders now include information that reflects the ACIP meningococcal recommendations published in March 2013. IAC also added an additional page to "Standing Orders for Administering Meningococcal Vaccine to Children & Teens"; it is now a two-page document.
IAC's Handouts for Patients & Staff web section offers healthcare professionals and the public more than 250 FREE English-language handouts (many also available in translation), which we encourage website users to print out, copy, and distribute widely. Back to top IAC revises its staff-education document “Healthcare Personnel Vaccination Recommendations” IAC recently updated Healthcare Personnel Vaccination Recommendations to add information from ACIP’s February 2013 recommendation about giving Tdap to pregnant women during each pregnancy. Back to top FEATURED RESOURCES Order IAC's popular full-size laminated versions of the 2013 U.S. immunization schedules today! IAC's laminated versions of the 2013 U.S. child/teen and adult immunization schedules are covered with a tough, washable coating that lets them stand up to a year's worth of use in every area of your healthcare setting where immunizations are given. Each has six pages (i.e., three double-sided pages) and is folded to measure 8.5" by 11".  
PRICING 1–4 copies: $7.50 each 5–19 copies: $5.50 each 20–99 copies: $4.50 each 100–499 copies: $4.00 each 500–999 copies: $3.50 each For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or email admininfo@immunize.org You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page. Back to top JOURNAL ARTICLES AND NEWSLETTERS CDC publishes report on Japan's 2013 nationwide rubella outbreak CDC published Nationwide Rubella Epidemic—Japan, 2013 in the June 14 issue of MMWR (pages 457–462). The first paragraph of the article and the concluding paragraph of the Editorial Note are reprinted below. Rubella usually is a mild, febrile rash illness in children and adults; however, infection early in pregnancy, particularly during the first 16 weeks, can result in miscarriage, stillbirth, or an infant born with birth defects (i.e., congenital rubella syndrome [CRS]). As of 2013, goals to eliminate rubella have been established in two World Health Organization regions (the Region of the Americas by 2010 and the European Region by 2015), and targets for accelerated rubella control and CRS prevention have been established by the Western Pacific Region (WPR). In 1976, Japan introduced single-antigen rubella vaccine in its national immunization program, targeting girls in junior high school. In 1989, a measles-mumps-rubella (MMR) vaccine was introduced, targeting children aged 12–72 months. However, adult males remain susceptible to rubella. From January 1 to May 1, 2013, a total of 5,442 rubella cases were reported through the rubella surveillance system in Japan, with the majority (77%) of cases occurring among adult males. Ten infants with CRS were reported during October 2012–May 1, 2013. Countries and regions establishing a goal of accelerated control or elimination of rubella should review their previous and current immunization policies and strategies to identify and vaccinate susceptible persons and to ensure high population immunity in all cohorts, both male and female. . . . The effects of this outbreak have been wide-ranging, both within Japan and internationally. In the Region of the Americas, where endemic rubella virus transmission has been interrupted, importations have occurred in the United States and Canada in 2013. The international spread of rubella virus from Japan provides a reminder that countries in regions that have eliminated rubella need to maintain high levels of vaccination coverage and high-quality surveillance to limit the spread and detect imported rubella virus. Back to top CDC publishes report on polio outbreaks in Somalia and Kenya in May 2013  |
About IZ Express
IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer
ISSN 2771-8085
IZ Express Disclaimer
ISSN 2771-8085
Editorial Information
-
Editor-in-ChiefKelly L. Moore, MD, MPH
-
Managing EditorJohn D. Grabenstein, RPh, PhD
-
Associate EditorSharon G. Humiston, MD, MPH
-
Writer/Publication CoordinatorTaryn Chapman, MS
Courtnay Londo, MA -
Style and Copy EditorMarian Deegan, JD
-
Web Edition ManagersArkady Shakhnovich
Jermaine Royes -
Contributing WriterLaurel H. Wood, MPA
-
Technical ReviewerKayla Ohlde